Renaissance Technologies
ALZN icon

Renaissance Technologies’s Alzamend Neuro ALZN Stock Holding History

Renaissance Technologies’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,667
Closed -$17.4K – 3429
2024
Q4 		$17.4K Buy
+1,667
New +$21.4K ﹤0.01% 3491
2024
Q3 		– Sell
-219
Closed -$7.77K – 3505
2024
Q2 		$7.77K Buy
219
+66
+43% +$3.77K ﹤0.01% 3428
2024
Q1 		$14K Buy
153
+40
+35% +$3.43K ﹤0.01% 3613
2023
Q4 		$9K Buy
113
+97
+606% +$15.9K ﹤0.01% 3646
2023
Q3 		$5K Buy
+16
New +$7.65K ﹤0.01% 3599
2023
Q1 		– Sell
-37
Closed -$28K – 3941
2022
Q4 		$28K Buy
+37
New +$53.6K ﹤0.01% 3899
2022
Q3 		– Sell
-48
Closed -$56K – 3997
2022
Q2 		$56K Buy
+48
New +$62.2K ﹤0.01% 3979

Other funds holding ALZN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CSB
City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's ALZN Position: Q1 2025 in Review

Renaissance Technologies sold out of Alzamend Neuro (ALZN) in Q1 2025, closing a stake of 1,667 shares — an estimated $17.4K sold.

Renaissance Technologies first reported a position in ALZN in Q2 2022 and held it in 7 quarters. The position peaked at $56K in Q2 2022. 8 funds tracked by Wall St. Rank hold ALZN as of Q1 2025.

  • Renaissance Technologies reported no remaining Alzamend Neuro position as of Q1 2025 after selling out during the quarter.
  • Renaissance Technologies sold 1,667 Alzamend Neuro shares in Q1 2025, an estimated $17.4K.
  • Renaissance Technologies first reported a position in Alzamend Neuro in Q2 2022 and held it in 7 quarters.
  • Renaissance Technologies's Alzamend Neuro position peaked at $56K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Alzamend Neuro as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.